Page last updated: 2024-10-30

leflunomide and Bronchiolitis, Exudative

leflunomide has been researched along with Bronchiolitis, Exudative in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morris, RE2
Huang, X1
Gregory, CR1
Billingham, ME1
Rowan, R1
Shorthouse, R2
Berry, GJ2
Reichenspurner, H1
Adams, B1
Soni, V1
Brazelton, T1
Reitz, BA1

Other Studies

2 other studies available for leflunomide and Bronchiolitis, Exudative

ArticleYear
Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
    Transplantation proceedings, 1995, Volume: 27, Issue:3

    Topics: Animals; Bronchiolitis Obliterans; Cyclosporine; Graft Occlusion, Vascular; Heart Transplantation; I

1995
Obliterative airway disease after heterotopic tracheal xenotransplantation in a concordant rodent model: pathogenesis and treatment.
    Transplantation proceedings, 1996, Volume: 28, Issue:2

    Topics: Airway Obstruction; Animals; Bronchiolitis Obliterans; Cricetinae; Cyclosporine; Immunosuppressive A

1996